Vitamin K for Osteoporosis

Verdict: Modest bone-density signal, unproven for fractures

Vitamin K (mainly K2) shows a modest, inconsistent benefit for spine bone mineral density in postmenopausal adults, but it has not been shown to reliably prevent fractures and is not part of standard osteoporosis treatment. Treat it as supportive of general bone maintenance at best, not a substitute for proven therapies.

B 🟡 B Preliminary Evidence Published with Warning

🔬Why this grade7-layer evidence engine

This earns a preliminary B because the evidence is split between a soft surrogate marker and the outcome that actually matters. Meta-analyses (PMID 31076817, n=8,762; PMID 37661104, n=1,290) and an MK-7 RCT (PMID 23525894, n=244) show vitamin K modestly slows the decline in lumbar-spine bone mineral density, but the effect at the hip and femoral neck is non-significant and heterogeneity is high. Bone density is only a stand-in for what patients care about: broken bones.

On fractures the picture is much weaker. The one meta-analysis reporting large fracture reductions (PMID 16801507, n=6,759) was driven almost entirely by Japanese trials using prescription-grade MK-4 at 45 mg/day, with high heterogeneity and small-study bias. When those trials are excluded, the updated meta-analysis (PMID 31076817) found no convincing fracture benefit, and the large ECKO trial of K1 5 mg/day (PMID 18922041, n=440) showed no effect on bone density. Everyday over-the-counter K1/MK-7 doses are far lower and cannot be assumed to match those Japanese prescription results.

Regulators and clinicians reflect this caution. EFSA recognizes vitamin K only for maintenance of normal bone, not osteoporosis treatment or fracture prevention; the NHS says a balanced diet supplies enough. Mayo Clinic, Cleveland Clinic, and Harvard all call the bone evidence early or conflicting, and the AACE osteoporosis algorithm omits vitamin K entirely, recommending exercise, calcium, vitamin D, and proven medications. Safety note: vitamin K antagonizes warfarin, so anyone on anticoagulants should keep intake stable and consult a clinician before supplementing.

⚖️

Scoring transparency

All scores computed by a 7-layer evidence engine — fully auditable
Raw score 0.59
D
C
B
A
S
← counter-evidence / ineffectiveeffective / strong evidence →
Final grade
B · Published with Warning
Confidence
83%
Highly consistent evidence
Evidence level
E2
Multiple high-quality MAs (≥2 independent, consistent)

How strongly each layer supports this effect

lower = less supportive
L5 Clinical bodiesAuthoritative stance
0.40
L1 ExamineGlobal benchmark
0.50
L11 AI re-checkIndependent read
0.50
L3 MechanismPlausibility
0.65
L2 PubMedPrimary literature
0.75
Against Mixed Supports
View the full decision path (audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.588
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 高品質 SR/MA 顯示 positive (2 篇 > 1 negative)
  4. tier_strict_requirement_check — Tier 條件達標,未降階
  5. detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

📄PubMed studies (5)L2 · primary research & systematic reviews

Vitamin K and the prevention of fractures: systematic review and meta-analysis of randomized controlled trials
PMID: 16801507 2006 統合分析 n = 6,759
Finding: Pooled RR for vertebral fracture 0.40 (95% CI 0.25-0.65), hip fracture RR 0.23 (95% CI 0.12-0.47), all non-vertebral RR 0.19 (95% CI 0.11-0.35); however benefit driven almost entirely by Japanese MK-4 45 mg/d trials with high heterogeneity and small-study bias.
Academic Effect size: [object Object]
View on PubMed
Vitamin K supplementation in postmenopausal women with osteopenia (ECKO trial): a randomized controlled trial
PMID: 18922041 2008 RCT (double-blind) n = 440
Finding: No significant effect of K1 5 mg/d on BMD at lumbar spine or total hip vs placebo; fewer clinical fractures with K1 (9 vs 20; HR 0.45, 95% CI 0.20-0.99) and fewer cancers, but trial not powered for these endpoints.
🟢 High quality Government Effect size: [object Object]
View on PubMed
Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women
PMID: 23525894 2013 RCT (double-blind) n = 244
Finding: MK-7 significantly reduced age-related decline in BMC and BMD at lumbar spine and femoral neck (but not total hip) and improved bone strength indices over 3 years; no fracture endpoint assessed.
⚠️ Industry-funded Effect size: [object Object]
View on PubMed
Effect of vitamin K on bone mineral density and fractures in adults: an updated systematic review and meta-analysis of randomised controlled trials
PMID: 31076817 2019 統合分析 n = 8,762
Finding: Vitamin K (any form) modestly preserved lumbar spine BMD (WMD 0.01 g/cm² favoring K) with high heterogeneity; no significant effect on total hip or femoral neck BMD; no convincing reduction in clinical fractures once Japanese MK-4 trials were excluded.
🟢 High quality Academic Effect size: [object Object]
View on PubMed
Effect of vitamin K2 on bone mineral density and serum cardiac biomarkers in adults: a systematic review and meta-analysis of randomized controlled trials
PMID: 37661104 2022 統合分析 n = 1,290
Finding: Vitamin K2 supplementation significantly improved lumbar spine BMD (SMD 0.40, 95% CI 0.20-0.60) but effect on femoral neck BMD was non-significant; no fracture endpoint pooled; substantial heterogeneity (I² > 60%).
Academic Effect size: [object Object]
View on PubMed

🏛️Regulatory & authoritative positionsL4/L5 · FDA / EMA / NIH ODS / Cochrane / Mayo …

L4a US FDA
Supportive
Vitamin K1 Injection is indicated for prophylaxis and treatment of vitamin K-deficiency bleeding in neonates source↗
L4b EU EFSA
Supportive
a cause and effect relationship has been established between the dietary intake of vitamin K and normal blood coagulation ... and the maintenance of normal bone source↗
L4c UK NHS
Cautious
You should be able to get all the vitamin K you need by eating a varied and balanced diet. Any vitamin K your body does not need immediately is stored in the liver for future use, so you do not need it in your diet every day. source↗
L4d TW TFDA / 衛福部
Supportive
成年男性 120 微克/日,女性 90 微克/日(足夠攝取量 AI) source↗
L4e WHO
Supportive
vitamin K1 should be given to all newborns as a single, intramuscular dose of 0.5–1 mg source↗
L5a NIH Office of Dietary Supplements
Supportive
Vitamin K, the generic name for a family of compounds with a common chemical structure of 2-methyl-1,4-naphthoquinone, is a fat-soluble vitamin source↗
L5b Mayo Clinic
Cautious
Vitamin K is necessary for blood to clot normally, may help keep bones healthy, and might have other benefits. source↗
L5c Cleveland Clinic
Cautious
Some early studies are showing that vitamin K2 supplements may reduce fractures and improve bone quality in people with osteoporosis. In Japan and other parts of Asia, one kind of vitamin K2 (MK-4), is used as a treatment for osteoporosis. source↗
L5d Harvard Health
Cautious
However, the results of clinical trials and meta-analyses have been conflicting whether vitamin K supplements reduce bone fractures. source↗
L5e Specialty Society (condition-mapped)
Not addressed
In addition to exercise, calcium and vitamin D supplements, you may also require one of the following medications: source↗
PMID 100% verifiedevery citation checked via NCBI Entrez
🔬5 PubMed studiesindependently re-checked by multiple sub-agents
engine_version: v1.0 claim_id: CLM-COND-osteoporosis-INT-vitamin-k-001 繁體中文版 →